...
首页> 外文期刊>Frontiers in Medicine >Outcomes of Combined Liver and Pancreas Transplantation: A Review of the SRTR National Database and a Report of the Largest Single Center Series
【24h】

Outcomes of Combined Liver and Pancreas Transplantation: A Review of the SRTR National Database and a Report of the Largest Single Center Series

机译:联合肝癌和胰腺移植的结果:对SRTR国家数据库的审查以及最大单中心系列的报告

获取原文
           

摘要

Purposes: This study was intended to summarize the characteristics and clinical outcome of Liver and Pancreas (LPTx) recipients in the Scientific Registry of Transplant Recipients (SRTR) database versus the largest series from the First Affiliated Hospital (FAH), Sun Yat-sen University. Methods: The clinical data of 23 patients who underwent LPTx from 2000 to 2016 in the United States and 31 patients who underwent modified LPTx procedure (known as simplified multivisceral transplantation [SMT]) from 2008 to 2017 in our center were reviewed. The indications, surgical techniques, patient and graft survival, and complications were compared between the two groups. Results: All recipients in the FAH group were diagnosed with type 2 diabetes mellitus, while 10 of 23 recipients were diagnosed with type 1 diabetes mellitus in the SRTR group. The 1-, 3-, and 5-year cumulative patient survival rates were 81%, 74%, and 74% in the FAH group, respectively, and 51%, 47%, and 37% in the SRTR group, respectively (P=0.023). No diabetes was observed during follow-up in the FAH group, while the diabetes recurrence rate was 22.2% in the SRTR group (P=0.03). Conclusion: With multiple techniques modified and indications changed, the SMT procedure yielded a preferable outcome compared to that of the traditional LPTx procedure in records of SRTR. SMT has become a treatment option for patients with end-stage liver disease and concurrent diabetes.
机译:目的:本研究旨在总结移植受者(SRTR)数据库科学登记处的肝脏和胰腺(LPTX)接受者的特征和临床结果与第一家附属医院(FAH),孙中山大学的最大系列。方法:综述了2000年至2016年2000年至2016年的LPTX患者的临床资料,并于2017年从2008年到2017年接受过修正的LPTX程序(称为简化的Multivivisceration [Smt])。在两组之间比较了两组之间的适应症,手术技术,患者和移植物生存和并发症。结果:FAH组中的所有接受者都被诊断为2型糖尿病,而在SRTR组中诊断出1种糖尿病的23名受者。 SRTR组的1-,3-和5年累积患者存活率分别为81%,74%和74%,分别为51%,47%和37%(P = 0.023)。在FAH组的随访期间没有观察到糖尿病,而SRTR组的糖尿病复发率为22.2%(P = 0.03)。结论:通过修改和适应症改变的多种技术,与SRTR记录中的传统LPTX程序相比,SMT程序得到了优选的结果。 SMT已成为患有末期肝病和糖尿病患者的治疗选择。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号